{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T07:46:52Z","timestamp":1791704812671,"version":"4.3.4"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013290","name":"National Key Research and Development Program of China Stem Cell and Translational Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013290","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.tranon.2026.103042","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:18:29Z","timestamp":1790295509000},"page":"103042","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["NAT-A exhibits anti-tumor activity against acquired epidermal growth factor receptor- tyrosine kinase inhibitor-resistant non-small cell lung cancer via inhibiting the \u03b2-catenin\/PKM2 axis"],"prefix":"10.1016","volume":"73","author":[{"given":"Liyun","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0030-6351","authenticated-orcid":false,"given":"Xinkai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahui","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guohua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihua","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hou wen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tranon.2026.103042_bib0001","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1056\/NEJMoa1713137","article-title":"Osimertinib in untreated EGFR- mutated advanced non-small-cell lung cancer","volume":"378","author":"Soria","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tranon.2026.103042_bib0002","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/caac.21871","article-title":"Cancer statistics, 2025, CA","volume":"75","author":"Siegel","year":"2021","journal-title":"Cancer J. Clin."},{"key":"10.1016\/j.tranon.2026.103042_bib0003","doi-asserted-by":"crossref","first-page":"e216","DOI":"10.1016\/j.cllc.2019.12.003","article-title":"Tyrosine kinase inhibitors for the treatment of EGFR mutation-positive non-small-cell lung cancer: a clash of the generations","volume":"21","author":"Shah","year":"2020","journal-title":"Clin. Lung Cancer"},{"key":"10.1016\/j.tranon.2026.103042_bib0004","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1200\/JCO.19.03123","article-title":"Emerging treatment paradigms for EGFR-mutant lung cancers progressing on osimertinib: a review","volume":"38","author":"Piper-Vallillo","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.tranon.2026.103042_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110225","article-title":"Inhibition of wnt\/\u03b2-catenin pathway reverses multi-drug resistance and EMT in Oct4+\/Nanog+ NSCLC cells","volume":"127","author":"Liu","year":"2020","journal-title":"Biomed. PharmacOther"},{"key":"10.1016\/j.tranon.2026.103042_bib0006","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1038\/s41388-023-02645-2","article-title":"Serine-arginine protein kinase 1 (SRPK1) promotes EGFR-TKI resistance by enhancing GSK3\u03b2 Ser9 autophosphorylation independent of its kinase activity in non-small-cell lung cancer","volume":"42","author":"Huang","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/j.tranon.2026.103042_bib0007","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.canlet.2017.02.029","article-title":"DDX17 nucleocytoplasmic shuttling promotes acquired gefitinib resistance in non-small cell lung cancer cells via activation of \u03b2-catenin","volume":"400","author":"Li","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.tranon.2026.103042_bib0008","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1038\/s41467-018-05626-2","article-title":"Notch3-dependent \u03b2-catenin signaling mediates EGFR TKI drug persistence in EGFR mutant NSCLC","volume":"9","author":"Arasada","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tranon.2026.103042_bib0009","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12943-023-01811-0","article-title":"Enhancement of TKI sensitivity in lung adenocarcinoma through m6A-dependent translational repression of wnt signaling by circ-FBXW7","volume":"22","author":"Li","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.tranon.2026.103042_bib0010","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1016\/j.celrep.2020.01.037","article-title":"Secreted pyruvate kinase M2 promotes lung cancer metastasis through activating the integrin Beta1\/FAK signaling pathway","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.tranon.2026.103042_bib0011","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/s41419-021-03990-4","article-title":"Lactate secreted by PKM2 upregulation promotes galectin-9-mediated immunosuppression via inhibiting NF-\u03bab pathway in HNSCC","volume":"12","author":"Chang","year":"2021","journal-title":"Cell Death. Dis."},{"key":"10.1016\/j.tranon.2026.103042_bib0012","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature10598","article-title":"Nuclear PKM2 regulates b-catenin transactivation upon EGFR activation","volume":"480","author":"Yang","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.tranon.2026.103042_bib0013","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.canlet.2018.11.030","article-title":"Gankyrin drives metabolic reprogramming to promote tumorigenesis, metastasis and drug resistance through activating beta-catenin\/c-myc signaling in human hepatocellular carcinoma","volume":"443","author":"Liu","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.tranon.2026.103042_bib0014","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/s41419-018-0887-0","article-title":"PAK2-c-myc-PKM2 axis plays an essential role in head and neck oncogenesis via regulating Warburg effect","volume":"9","author":"Gupta","year":"2018","journal-title":"Cell Death. Dis."},{"key":"10.1016\/j.tranon.2026.103042_bib0015","doi-asserted-by":"crossref","first-page":"8629","DOI":"10.2147\/OTT.S239134","article-title":"Cryptanshinone inhibits the glycolysis and inhibits cell migration through PKM2\/beta-catenin axis in breast cancer","volume":"13","author":"Zhou","year":"2020","journal-title":"Onco Targets. Ther."},{"key":"10.1016\/j.tranon.2026.103042_bib0016","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1021\/acschembio.8b00325","article-title":"Directed accumulation of anticancer depsipeptides by characterization of neoantimycins biosynthetic pathway and an NADPH-dependent reductase","volume":"13","author":"Zhou","year":"2018","journal-title":"ACS. Chem. Biol."},{"key":"10.1016\/j.tranon.2026.103042_bib0017","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3389\/fchem.2019.00481","article-title":"Compound discovery and structure-activity relationship study of neoantimycins against drug- resistant cancer cells","volume":"7","author":"Lin","year":"2019","journal-title":"Front. Chem."},{"key":"10.1016\/j.tranon.2026.103042_bib0018","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.3389\/fphar.2019.01042","article-title":"Neoantimycin F, a streptomyces-derived natural product induces mitochondria-related apoptotic death in Human non-small cell lung cancer cells","volume":"10","author":"Liu","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.tranon.2026.103042_bib0019","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.apsb.2023.10.013","article-title":"A novel TNKS\/USP25 inhibitor blocks the Wnt pathway to overcome multi-drug resistance in TNKS-overexpressing colorectal cancer","volume":"14","author":"Zhu","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.tranon.2026.103042_bib0020","doi-asserted-by":"crossref","unstructured":"H.R Christofk, H.MG. Vander, M.H Harris, et al. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature.2008; 452:230-233..","DOI":"10.1038\/nature06734"},{"key":"10.1016\/j.tranon.2026.103042_bib0021","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1038\/s41590-024-01963-1","article-title":"Deficiency of metabolic regulator PKM2 activates the pentose phosphate pathway and generates TCF1(+) progenitor CD8(+) T cells to improve immunotherapy","volume":"25","author":"Markowitz","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.tranon.2026.103042_bib0022","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.7150\/thno.51797","article-title":"Cisplatin-resistant NSCLC cells induced by hypoxia transmit resistance to sensitive cells through exosomal PKM2","volume":"11","author":"Wang","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.tranon.2026.103042_bib0023","doi-asserted-by":"crossref","first-page":"eabb5727","DOI":"10.1126\/scisignal.abb5727","article-title":"EGF promotes DKK1 transcription in hepatocellular carcinoma by enhancing the phosphorylation and acetylation of histone H3","volume":"13","author":"Niu","year":"2020","journal-title":"Sci. Signal."},{"key":"10.1016\/j.tranon.2026.103042_bib0024","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1038\/s41388-025-03426-9","article-title":"SETD5 facilitates stemness and represses ferroptosis via m6A-mediating PKM2 stabilization in non-small cell lung cancer","volume":"44","author":"Liu","year":"2025","journal-title":"Oncogene"},{"key":"10.1016\/j.tranon.2026.103042_bib0025","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.canlet.2020.05.009","article-title":"LncRNA H19 downregulation confers erlotinib resistance through upregulation of PKM2 and phosphorylation of AKT in EGFR-mutant lung cancers","volume":"486","author":"Chen","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.tranon.2026.103042_bib0026","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.chembiol.2019.11.010","article-title":"Identification of a small compound targeting PKM2-regulated signaling using 2D gel electrophoresis-based proteome-wide CETSA","volume":"27","author":"Nagasawa","year":"2020","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.tranon.2026.103042_bib0027","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/s41591-021-01450-2","article-title":"Toward personalized treatment approaches for non-small-cell lung cancer","volume":"27","author":"Wang","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.tranon.2026.103042_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119608","article-title":"SOX9 promotes epidermal growth factor receptor-tyrosine kinase inhibitor resistance via targeting \u03b2-catenin and epithelial to mesenchymal transition in lung cancer","volume":"277","author":"Tripathi","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.tranon.2026.103042_bib0029","doi-asserted-by":"crossref","first-page":"5036","DOI":"10.1021\/ol502376e","article-title":"Rare streptomyces N-formyl amino-salicylamides inhibit oncogenic K-ras","volume":"16","author":"Salim","year":"2014","journal-title":"Org. Lett."},{"key":"10.1016\/j.tranon.2026.103042_bib0030","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/ja.2005.25","article-title":"A novel GRP78 molecular chaperone down-regulator isolated from Streptomyces violaceoniger","volume":"58","author":"Umeda","year":"2005","journal-title":"J. Antibiot."},{"key":"10.1016\/j.tranon.2026.103042_bib0031","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/ja.2007.82","article-title":"Novel GRP78 molecular chaperone expression down-regulators JBIR-04 and -05 isolated from Streptomyces violaceoniger","volume":"60","author":"Izumikawa","year":"2007","journal-title":"J. Antibiot."},{"key":"10.1016\/j.tranon.2026.103042_bib0032","doi-asserted-by":"crossref","first-page":"4318","DOI":"10.1038\/s41388-022-02438-z","article-title":"P21-activated kinase 2-mediated beta-catenin signaling promotes cancer stemness and osimertinib resistance in EGFR-mutant non-small-cell lung cancer","volume":"41","author":"Yi","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.tranon.2026.103042_bib0033","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bbrc.2023.01.018","article-title":"A Wnt\/beta-catenin\u2002signaling inhibitor, IMU1003, suppresses the emergence of osimertinib-resistant colonies from gefitinib-resistant non-small cell lung cancer cells","volume":"645","author":"Katagiri","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.tranon.2026.103042_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.107357","article-title":"Isovitexin potentiated the antitumor activity of cisplatin by inhibiting the glucose metabolism of lung cancer cells and reduced cisplatin-induced immunotoxicity in mice","volume":"94","author":"Chen","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.tranon.2026.103042_bib0035","article-title":"Shenmai injection supresses glycolysis and enhances cisplatin cytotoxicity in cisplatin-resistant A549\/DDP cells via the AKT-mTOR-c-Myc signaling pathway","author":"Sun","year":"2020","journal-title":"BioMed. Res. Int."},{"key":"10.1016\/j.tranon.2026.103042_bib0036","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.omtn.2018.04.001","article-title":"miR372 Promotes progression of liver cancer cells by upregulating erbB-2 through enhancement of YB-1","volume":"11","author":"Lin","year":"2018","journal-title":"Mol. Ther. Nucleic. Acids."},{"key":"10.1016\/j.tranon.2026.103042_bib0037","doi-asserted-by":"crossref","first-page":"ra73","DOI":"10.1126\/scisignal.2000431","article-title":"Tyrosine phosphorylation inhibits PKM2 to promote the Warburg effect and tumor growth","volume":"2","author":"Hitosugi","year":"2009","journal-title":"Sci. Signal."},{"key":"10.1016\/j.tranon.2026.103042_bib0038","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.7150\/thno.103722","article-title":"A novel pathway for stemness propagation and chemoresistance in non-small cell lung cancer via phosphorylated PKM2-loaded small extracellular vesicles","volume":"15","author":"Wang","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.tranon.2026.103042_bib0039","doi-asserted-by":"crossref","first-page":"4224","DOI":"10.1002\/ptr.7903","article-title":"Anti-warburg effect via generation of ROS and inhibition of PKM2\/beta-catenin mediates apoptosis of lambertianic acid in prostate cancer cells","volume":"37","author":"Pak","year":"2023","journal-title":"PhytOther Res."},{"key":"10.1016\/j.tranon.2026.103042_bib0040","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.3390\/cancers16142533","article-title":"Sanguinarine induces necroptosis of HCC by targeting PKM2 mediated energy metabolism","volume":"16","author":"Kong","year":"2024","journal-title":"Cancers"}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326003785?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326003785?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T07:28:19Z","timestamp":1791703699000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523326003785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":40,"alternative-id":["S1936523326003785"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2026.103042","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NAT-A exhibits anti-tumor activity against acquired epidermal growth factor receptor- tyrosine kinase inhibitor-resistant non-small cell lung cancer via inhibiting the \u03b2-catenin\/PKM2 axis","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2026.103042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103042"}}